🔗 Visit the ClinicalTrials.gov page for NCT02503774
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Anti-CD73 in cancer immunotherapy: awakening new opportunities. | Trends Cancer | 2016 | 0.90 |
| 2 | Immune checkpoint inhibitors: therapeutic advances in melanoma. | Ann Transl Med | 2015 | 0.87 |
| 3 | Targeting CD73 in the tumor microenvironment with MEDI9447. | Oncoimmunology | 2016 | 0.84 |
| 4 | Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy. | Front Oncol | 2016 | 0.77 |
| 5 | A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer. | Curr Opin Pharmacol | 2016 | 0.77 |